A machine-learning model using cardiac MRI and clinical parameters predicts major adverse cardiovascular events (MACE) in STEMI patients with higher accuracy than traditional methods.
Key Details
- 1Model integrates cardiac MRI and clinical data for long-term MACE prediction.
- 2Study included 1,066 STEMI patients from 2015-2023 who underwent MRI within 7 days post-PCI.
- 3ML model achieved external test set AUC of 0.91, outperforming clinical risk scores (AUC: 0.66-0.86) and Cox regression models.
- 4Sensitivity, specificity, and accuracy reached 82.7%, 84.5%, and 84.1% respectively.
- 5Stratified patients into distinct risk groups effectively (log-rank p < 0.001).
- 6Experts note need for further prospective studies and consideration of medical costs before clinical adoption.
Why It Matters
This work underscores the growing role of MRI-based AI tools in cardiovascular risk stratification, suggesting ML integration could personalize and improve outcome prediction. However, real-world impact and cost-effectiveness require further validation before routine use.
Source
AuntMinnie
Related News
•Radiology Business
RadNet AI Tool Reduces Unnecessary Prostate Biopsies by 19%
RadNet's DeepHealth AI tool can help avoid nearly 1 in 5 prostate biopsies while maintaining high cancer detection sensitivity.
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.
•Radiology Business
FDA Clears AIRS Medical AI for Rapid MRI Body Composition Analysis
AIRS Medical's SwiftSight Body Composition AI software receives FDA 510(k) clearance for automated MRI-based body composition reporting.